METTL3 and metabolic dysfunction-associated steatotic liver disease: In this study, we investigated the oncogenic role of METTL3 in NAFLD-HCC using liver-specific Mettl3 transgenic mice and Mettl3 knockout mice and established an oncogenic effect of METTL3 in NAFLD-HCC progression.